The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $584,447 in first-year total cost, median $292,224.
Most frequent study sections
- Special Emphasis Panel[ZDK1 GRB-T (M2)]1
- Special Emphasis Panel[ZDK1 GRB-T (O1)]1
Most frequent institutions
- ELECTRONIC BIOSCIENCES, INC.1
- WAVE 80 BIOSCIENCES, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Multi-Platform Homogeneous Multiplexed Autoantibody Assay Based on Liquid Micropiston-Enhanced Time-Resolved Forster Resonance Energy Transfer1R43DK134864-01 | DROITCOUR, AMY | WAVE 80 BIOSCIENCES, INC., CA | $299,930 | ZDK1 |
| 2023 | Point-of-Care Assay for Type 1 Diabetes Diagnosis and Prognostication1R43DK136652-01 | ERVIN, ERIC | ELECTRONIC BIOSCIENCES, INC., CA | $284,517 | ZDK1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.